Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-062130
Filing Date
2023-11-09
Accepted
2023-11-09 16:30:35
Documents
78
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q cmra-20230930.htm   iXBRL 10-Q 2241478
2 EX-31.1 cmra-ex31_1.htm EX-31.1 24532
3 EX-31.2 cmra-ex31_2.htm EX-31.2 24188
4 EX-32.1 cmra-ex32_1.htm EX-32.1 17518
5 EX-32.2 cmra-ex32_2.htm EX-32.2 15508
  Complete submission text file 0000950170-23-062130.txt   8503585

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cmra-20230930_lab.xml EX-101.LAB 515799
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cmra-20230930_cal.xml EX-101.CAL 49416
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cmra-20230930.xsd EX-101.SCH 79925
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cmra-20230930_def.xml EX-101.DEF 285327
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cmra-20230930_pre.xml EX-101.PRE 397168
72 EXTRACTED XBRL INSTANCE DOCUMENT cmra-20230930_htm.xml XML 1282747
Mailing Address 12 GILL STREET SUITE 4650 WOBURN MA 01801
Business Address 12 GILL STREET SUITE 4650 WOBURN MA 01801 (617)871-2101
Comera Life Sciences Holdings, Inc. (Filer) CIK: 0001907685 (see all company filings)

EIN.: 874706968 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41403 | Film No.: 231393072
SIC: 2834 Pharmaceutical Preparations